What is Ducommun Inc Del's earnings per share (EPS)?

Ducommun Inc Del (DCO) reported diluted earnings per share of $-2.50 for fiscal year 2025. This represents a -273.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ducommun Inc Del Financials

DCO

Source SEC Filings (10-K/10-Q) Data as of Apr 4, 2026 Currency USD FYE December

This page shows Ducommun Inc Del (DCO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DCO FY2025 2026-05-08

Ducommun’s FY2025 shows product-level margin improvement overwhelmed by a below-the-line cost surge that reversed cash generation.

In the latest year, gross margin widened to 26.9% while operating cash flow fell to -$33.4M, showing the strain came after production rather than from weaker unit economics. At the same time, long-term debt rose to $300M from $230.7M, so the healthy-looking current ratio reflects balance-sheet support more than cash created by the business.

Revenue growth stopped translating into operating leverage. Free cash flow swung from $20.1M to -$48.6M, so the earnings setback was matched by real cash consumption instead of staying an accounting-only issue. Over the last three annual periods, gross margin climbed from 21.6% to 26.9%, so the latest loss does not read like a deterioration in core production economics.

Short-term liquidity remains comfortable at 3.5x current ratio, but that cushion is not the same as balance-sheet slack. Cash was only $45.3M against long-term debt of $300M, which means liquidity was preserved with financing even as internal cash generation turned negative.

Financial Health Signals

Financial Health Score 48/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Ducommun Inc Del's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Ducommun Inc Del has an operating margin of -4.3%, meaning the company retains $-4 of operating profit per $100 of revenue. This results in a moderate score of 36/100, indicating healthy but not exceptional operating efficiency. This is down from 5.4% the prior year.

Growth

Ducommun Inc Del's revenue grew a modest 4.9% year-over-year to $824.8M. This slow but positive growth earns a score of 48/100.

Leverage

Ducommun Inc Del has a moderate D/E ratio of 0.45. This balance of debt and equity financing earns a leverage score of 62/100.

Liquidity

With a current ratio of 3.49, Ducommun Inc Del holds $3.49 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 82/100.

Cash Flow

While Ducommun Inc Del generated -$33.4M in operating cash flow, capex of $15.2M consumed most of it, leaving -$48.6M in free cash flow. This results in a low score of 25/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Ducommun Inc Del's ROE of -5.7% shows moderate profitability relative to equity, earning a score of 35/100. This is down from 3.2% the prior year.

Altman Z-Score Safe

4.55

Ducommun Inc Del scores 4.55, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.6B) relative to total liabilities ($524.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak

3/9

Ducommun Inc Del passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.89x

For every $1 of reported earnings, Ducommun Inc Del generates $0.89 in operating cash flow (-$33.4M OCF vs -$37.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$824.8M

YoY+4.9%

5Y CAGR+5.6%

10Y CAGR+2.2%

Ducommun Inc Del generated $824.8M in revenue in fiscal year 2025. This represents an increase of 4.9% from the prior year.

EBITDA

-$2.1M

YoY-102.7%

Ducommun Inc Del's EBITDA was -$2.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 102.7% from the prior year.

Net Income

-$37.4M

YoY-272.3%

Ducommun Inc Del reported -$37.4M in net income in fiscal year 2025. This represents a decrease of 272.3% from the prior year.

EPS (Diluted)

$-2.50

YoY-273.6%

Ducommun Inc Del earned $-2.50 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 273.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$48.6M

YoY-342.6%

Ducommun Inc Del generated -$48.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 342.6% from the prior year.

Cash & Debt

$45.3M

YoY+21.9%

5Y CAGR-4.3%

10Y CAGR+23.6%

Ducommun Inc Del held $45.3M in cash against $300.0M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

15M

YoY+1.1%

5Y CAGR+4.9%

Ducommun Inc Del had 15M shares outstanding in fiscal year 2025. This represents an increase of 1.1% from the prior year.

Margins & Returns

Gross Margin

26.9%

YoY+1.8pp

5Y CAGR+5.0pp

10Y CAGR+11.7pp

Ducommun Inc Del's gross margin was 26.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.8 percentage points from the prior year.

Operating Margin

-4.3%

YoY-9.7pp

5Y CAGR-11.6pp

10Y CAGR+7.0pp

Ducommun Inc Del's operating margin was -4.3% in fiscal year 2025, reflecting core business profitability. This is down 9.7 percentage points from the prior year.

Net Margin

-4.5%

YoY-7.3pp

5Y CAGR-9.2pp

10Y CAGR+6.7pp

Ducommun Inc Del's net profit margin was -4.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 7.3 percentage points from the prior year.

Return on Equity

-5.7%

YoY-8.8pp

5Y CAGR-14.5pp

10Y CAGR+34.7pp

Ducommun Inc Del's ROE was -5.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 8.8 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$15.2M

YoY+7.8%

5Y CAGR+4.0%

10Y CAGR-0.4%

Ducommun Inc Del invested $15.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 7.8% from the prior year.

DCO Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$824.8M+4.9%	$786.4M+3.9%	$757.0M+6.2%	$712.5M+10.4%	$645.4M+2.6%	$628.9M
Cost of Revenue	$603.2M+2.4%	$589.2M-0.8%	$593.8M+4.5%	$568.2M+13.0%	$503.0M+2.4%	$491.2M
Gross Profit	$221.6M+12.3%	$197.3M+20.9%	$163.2M+13.1%	$144.3M+1.3%	$142.5M+3.4%	$137.7M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$147.8M-0.5%	$148.6M+24.1%	$119.7M+21.7%	$98.4M+5.1%	$93.6M+4.2%	$89.8M
Operating Income	-$35.7M-184.6%	$42.2M+46.0%	$28.9M-27.3%	$39.8M-18.6%	$48.9M+7.4%	$45.5M
Interest Expense	N/A	N/A	-$20.8M-79.5%	-$11.6M-3.4%	-$11.2M+18.1%	-$13.7M
Income Tax	-$9.9M-288.8%	$5.2M+1061.6%	$451K-90.1%	$4.5M-87.0%	$34.9M+1145.0%	$2.8M
Net Income	-$37.4M-272.3%	$21.7M+36.1%	$15.9M-44.7%	$28.8M-78.8%	$135.5M+364.6%	$29.2M
EPS (Diluted)	$-2.50-273.6%	$1.44+26.3%	$1.14-51.1%	$2.33-78.9%	$11.06+351.4%	$2.45

Metric	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$209.0M-3.7%	$217.1M+1.3%	$214.4M+6.8%	$200.8M+4.3%	$192.5M-2.4%	$197.2M-2.1%	$201.4M+2.7%	$196.1M
Cost of Revenue	$152.8M-3.2%	$157.9M+1.6%	$155.5M+5.2%	$147.8M+4.1%	$142.0M-5.8%	$150.8M+1.4%	$148.7M+2.6%	$145.0M
Gross Profit	$56.2M-5.1%	$59.2M+0.5%	$59.0M+11.3%	$53.0M+5.0%	$50.5M+8.7%	$46.4M-11.9%	$52.7M+3.1%	$51.1M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$40.5M+18.8%	$34.1M+0.3%	$34.0M-1.8%	$34.6M-23.1%	$45.0M+33.9%	$33.6M-4.7%	$35.3M-24.1%	$46.6M
Operating Income	$15.7M-6.9%	$16.9M+122.4%	-$75.3M-524.9%	$17.7M+256.3%	$5.0M-54.2%	$10.9M-29.6%	$15.4M+368.4%	$3.3M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$1.8M-48.8%	$3.5M+120.1%	-$17.4M-569.6%	$3.7M+1096.5%	$310K-53.2%	$662K-69.8%	$2.2M+44000.0%	-$5K
Net Income	$9.9M+6.4%	$9.3M+115.3%	-$60.8M-576.9%	$12.8M+809.7%	$1.4M-78.7%	$6.6M-30.0%	$9.4M+1491.1%	-$676K
EPS (Diluted)	$0.64+6.7%	$0.60+114.8%	$-4.06-583.3%	$0.84+833.3%	$0.09-79.5%	$0.44-30.2%	$0.63+1360.0%	$-0.05

DCO Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.2B+5.3%	$1.1B+0.5%	$1.1B+9.7%	$1.0B+4.4%	$978.7M+16.9%	$837.3M
Current Assets	$626.0M+10.2%	$568.1M+3.4%	$549.6M+4.2%	$527.3M+7.1%	$492.6M+20.1%	$410.3M
Cash & Equivalents	$45.3M+21.9%	$37.1M-13.4%	$42.9M-7.3%	$46.2M-39.4%	$76.3M+35.2%	$56.5M
Inventory	$182.8M-7.2%	$197.0M-1.1%	$199.2M+16.3%	$171.2M+13.4%	$150.9M+16.8%	$129.2M
Accounts Receivable	$124.4M+13.4%	$109.7M+4.8%	$104.7M+0.7%	$104.0M+43.9%	$72.3M+24.5%	$58.0M
Goodwill	$244.6M0.0%	$244.6M0.0%	$244.6M+20.3%	$203.4M-0.1%	$203.7M+19.2%	$170.8M
Total Liabilities	$524.9M+17.7%	$446.2M-8.0%	$484.8M-2.2%	$495.5M-1.7%	$504.1M-0.8%	$508.0M
Current Liabilities	$179.2M+2.1%	$175.5M-4.5%	$183.7M-7.9%	$199.4M+22.7%	$162.6M+13.8%	$142.9M
Long-Term Debt	$300.0M+30.1%	$230.7M-10.7%	$258.2M+6.6%	$242.2M-13.7%	$280.7M-10.5%	$313.6M
Total Equity	$661.5M-2.7%	$680.1M+6.9%	$636.1M+20.9%	$526.0M+10.8%	$474.6M+44.1%	$329.3M
Retained Earnings	$406.3M-8.4%	$443.7M+5.1%	$422.0M+3.9%	$406.1M+7.6%	$377.3M+56.1%	$241.7M

Metric	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$1.2B-0.1%	$1.2B-5.1%	$1.3B+9.8%	$1.1B+1.0%	$1.1B+0.2%	$1.1B-0.3%	$1.1B-0.2%	$1.1B
Current Assets	$633.9M+1.3%	$626.0M-8.2%	$681.9M+14.4%	$596.3M+3.2%	$578.1M+1.8%	$568.1M-0.4%	$570.5M+0.2%	$569.5M
Cash & Equivalents	$39.1M-13.7%	$45.3M-11.1%	$50.9M+37.2%	$37.1M+20.8%	$30.7M-17.3%	$37.1M-0.3%	$37.3M+26.7%	$29.4M
Inventory	$186.3M+1.9%	$182.8M-6.1%	$194.7M-1.9%	$198.6M+0.3%	$198.0M+0.5%	$197.0M+6.0%	$185.8M-8.0%	$201.8M
Accounts Receivable	$137.0M+10.1%	$124.4M+11.8%	$111.3M-5.7%	$118.0M+0.2%	$117.8M+7.4%	$109.7M+1.8%	$107.7M+1.1%	$106.6M
Goodwill	$244.6M0.0%	$244.6M0.0%	$244.6M0.0%	$244.6M0.0%	$244.6M0.0%	$244.6M0.0%	$244.6M0.0%	$244.6M
Total Liabilities	$515.5M-1.8%	$524.9M-12.7%	$601.1M+38.7%	$433.3M-0.7%	$436.3M-2.2%	$446.2M-4.2%	$465.9M-2.3%	$476.9M
Current Liabilities	$172.6M-3.7%	$179.2M-46.4%	$334.3M+83.2%	$182.5M+6.3%	$171.7M-2.2%	$175.5M-0.9%	$177.0M-4.4%	$185.1M
Long-Term Debt	$298.8M-0.4%	$300.0M+39.1%	$215.6M-1.4%	$218.8M-5.2%	$230.7M0.0%	$230.7M-6.6%	$246.9M-2.0%	$251.9M
Total Equity	$669.8M+1.3%	$661.5M+1.9%	$649.2M-8.0%	$705.8M+2.0%	$692.1M+1.8%	$680.1M+2.4%	$664.1M+1.3%	$655.3M
Retained Earnings	$416.2M+2.4%	$406.3M+2.3%	$397.0M-13.3%	$457.8M+2.9%	$445.1M+0.3%	$443.7M+1.5%	$437.1M+2.2%	$427.7M

DCO Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$33.4M-197.7%	$34.2M+10.0%	$31.1M-4.9%	$32.7M+5884.1%	-$565K-104.5%	$12.6M
Capital Expenditures	$15.2M+7.8%	$14.1M-27.6%	$19.5M-0.8%	$19.7M+16.8%	$16.9M+34.8%	$12.5M
Free Cash Flow	-$48.6M-342.6%	$20.1M+73.7%	$11.5M-11.1%	$13.0M+174.5%	-$17.4M-17355.4%	$101K
Investing Cash Flow	-$13.1M+5.6%	-$13.9M+89.6%	-$133.5M-593.8%	-$19.2M-133.3%	$57.8M+1155.4%	-$5.5M
Financing Cash Flow	$54.7M+310.3%	-$26.0M-126.2%	$99.0M+327.7%	-$43.5M-16.5%	-$37.3M-483.2%	$9.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$11.2M+115.0%	-$74.7M-512.6%	$18.1M-19.2%	$22.4M+2806.6%	$771K-95.8%	$18.4M+32.1%	$13.9M+302.7%	$3.5M
Capital Expenditures	$2.9M-27.8%	$4.1M+94.5%	$2.1M-51.0%	$4.3M-11.4%	$4.8M+25.1%	$3.8M+93.6%	$2.0M-40.1%	$3.3M
Free Cash Flow	$8.3M+110.5%	-$78.8M-591.9%	$16.0M-11.8%	$18.1M+548.6%	-$4.0M-127.7%	$14.6M+21.9%	$12.0M+8201.4%	$144K
Investing Cash Flow	-$2.9M+29.0%	-$4.1M-98.3%	-$2.1M+6.2%	-$2.2M+54.6%	-$4.8M-32.8%	-$3.6M-82.4%	-$2.0M+40.1%	-$3.3M
Financing Cash Flow	-$14.5M-119.9%	$73.1M+3353.0%	-$2.2M+83.8%	-$13.8M-485.6%	-$2.4M+84.2%	-$14.9M-264.6%	-$4.1M-45.9%	-$2.8M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

DCO Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	26.9%+1.8pp	25.1%+3.5pp	21.6%+1.3pp	20.3%-1.8pp	22.1%+0.2pp	21.9%
Operating Margin	-4.3%-9.7pp	5.4%+1.6pp	3.8%-1.8pp	5.6%-2.0pp	7.6%+0.3pp	7.2%
Net Margin	-4.5%-7.3pp	2.8%+0.7pp	2.1%-1.9pp	4.0%-17.0pp	21.0%+16.4pp	4.6%
Return on Equity	-5.7%-8.8pp	3.2%+0.7pp	2.5%-3.0pp	5.5%-23.1pp	28.6%+19.7pp	8.9%
Return on Assets	-3.1%-5.1pp	1.9%+0.5pp	1.4%-1.4pp	2.8%-11.0pp	13.9%+10.4pp	3.5%
Current Ratio	3.49+0.3	3.24+0.2	2.99+0.3	2.64-0.4	3.03+0.2	2.87
Debt-to-Equity	0.45+0.1	0.34-0.1	0.41-0.1	0.46-0.1	0.59-0.4	0.95
FCF Margin	-5.9%-8.4pp	2.5%+1.0pp	1.5%-0.3pp	1.8%+4.5pp	-2.7%-2.7pp	0.0%

Metric	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	26.9%-0.4pp	27.3%-0.2pp	27.5%+1.1pp	26.4%+0.2pp	26.2%+2.7pp	23.5%-2.6pp	26.2%+0.1pp	26.1%
Operating Margin	7.5%-0.3pp	7.8%+42.9pp	-35.1%-44.0pp	8.8%+6.3pp	2.6%-2.9pp	5.5%-2.1pp	7.7%+6.0pp	1.7%
Net Margin	4.7%+0.4pp	4.3%+32.7pp	-28.4%-34.7pp	6.3%+5.6pp	0.7%-2.6pp	3.3%-1.3pp	4.7%+5.0pp	-0.3%
Return on Equity	1.5%+0.1pp	1.4%+10.8pp	-9.4%-11.2pp	1.8%+1.6pp	0.2%-0.8pp	1.0%-0.5pp	1.4%+1.5pp	-0.1%
Return on Assets	0.8%+0.0pp	0.8%+5.7pp	-4.9%-6.0pp	1.1%+1.0pp	0.1%-0.5pp	0.6%-0.3pp	0.8%+0.9pp	-0.1%
Current Ratio	3.67+0.2	3.49+1.5	2.04-1.2	3.27-0.1	3.37+0.1	3.24+0.0	3.22+0.1	3.08
Debt-to-Equity	0.450.0	0.45+0.1	0.33+0.0	0.31-0.0	0.330.0	0.34-0.0	0.37-0.0	0.38
FCF Margin	4.0%+40.2pp	-36.3%-43.7pp	7.5%-1.6pp	9.0%+11.1pp	-2.1%-9.5pp	7.4%+1.4pp	5.9%+5.9pp	0.1%

Similar Companies

Astronics ATRO

$3.5B

Redwire Corporation RDW

$2.2B

Cadre Hldgs Inc CDRE

$1.3B

V2X VVX

$2.6B

Eve Holding Inc EVEX

$842.9M

Frequently Asked Questions

What is Ducommun Inc Del's annual revenue?

Ducommun Inc Del (DCO) reported $824.8M in total revenue for fiscal year 2025. This represents a 4.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ducommun Inc Del's revenue growing?

Ducommun Inc Del (DCO) revenue grew by 4.9% year-over-year, from $786.4M to $824.8M in fiscal year 2025.

Is Ducommun Inc Del profitable?

No, Ducommun Inc Del (DCO) reported a net income of -$37.4M in fiscal year 2025, with a net profit margin of -4.5%.

What is Ducommun Inc Del's EBITDA?

Ducommun Inc Del (DCO) had EBITDA of -$2.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Ducommun Inc Del have?

As of fiscal year 2025, Ducommun Inc Del (DCO) had $45.3M in cash and equivalents against $300.0M in long-term debt.

What is Ducommun Inc Del's gross margin?

Ducommun Inc Del (DCO) had a gross margin of 26.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Ducommun Inc Del's operating margin?

Ducommun Inc Del (DCO) had an operating margin of -4.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Ducommun Inc Del's net profit margin?

Ducommun Inc Del (DCO) had a net profit margin of -4.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Ducommun Inc Del's return on equity (ROE)?

Ducommun Inc Del (DCO) has a return on equity of -5.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Ducommun Inc Del's free cash flow?

Ducommun Inc Del (DCO) generated -$48.6M in free cash flow during fiscal year 2025. This represents a -342.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Ducommun Inc Del's operating cash flow?

Ducommun Inc Del (DCO) generated -$33.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Ducommun Inc Del's total assets?

Ducommun Inc Del (DCO) had $1.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Ducommun Inc Del's capital expenditures?

Ducommun Inc Del (DCO) invested $15.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Ducommun Inc Del have outstanding?

Ducommun Inc Del (DCO) had 15M shares outstanding as of fiscal year 2025.

What is Ducommun Inc Del's current ratio?

Ducommun Inc Del (DCO) had a current ratio of 3.49 as of fiscal year 2025, which is generally considered healthy.

What is Ducommun Inc Del's debt-to-equity ratio?

Ducommun Inc Del (DCO) had a debt-to-equity ratio of 0.45 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Ducommun Inc Del's return on assets (ROA)?

Ducommun Inc Del (DCO) had a return on assets of -3.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Ducommun Inc Del's cash runway?

Based on fiscal year 2025 data, Ducommun Inc Del (DCO) had $45.3M in cash against an annual operating cash burn of $33.4M. This gives an estimated cash runway of approximately 16 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Ducommun Inc Del's Altman Z-Score?

Ducommun Inc Del (DCO) has an Altman Z-Score of 4.55, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Ducommun Inc Del's Piotroski F-Score?

Ducommun Inc Del (DCO) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Ducommun Inc Del's earnings high quality?

Ducommun Inc Del (DCO) has an earnings quality ratio of 0.89x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Ducommun Inc Del?

Ducommun Inc Del (DCO) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.